Edition:
United Kingdom

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.83USD
5:04pm GMT
Change (% chg)

$-0.00 (-0.50%)
Prev Close
$0.83
Open
$0.84
Day's High
$0.84
Day's Low
$0.83
Volume
5,143
Avg. Vol
159,697
52-wk High
$5.02
52-wk Low
$0.76

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Elliot Maza

61 2017 President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Secretary, Director

Anthony Fiorino

2017 Chief Operating Officer, Chief Medical Officer

John Clark

2017 Controller

Cameron Durrant

54 2015 Lead Independent Director

Daniel Teper

55 2017 Director